Literature DB >> 7046672

Abnormalities of sodium and H2O handling in chronic obstructive lung disease.

M O Farber, L R Roberts, M H Weinberger, G L Robertson, N S Fineberg, F Manfredi.   

Abstract

The pathogenesis of edema and hyponatremia in chronic obstructive lung disease (COLD), is poorly understood. Previously, in nonedematous patients with hypercapnia, small increases in plasma renin activity occurred, which prompted this study. In 25 hypercapnic, edematous, often hyponatremic patients with COLD, we measured renal hemodynamics, H2O, and sodium (Na+) excretion, plasma levels of renin activity (PRA), plasma levels of aldosterone (PA), and the plasma arginine vasopressin (AVP)-osmolality relationship. A high prevalence of elevated PRA, PA, and AVP levels excessively high for plasma osmolality was observed. Elevated PRA and Pa correlated with the inability to excrete Na+; an elevated AVP level correlated with the inability to excrete H2). These data suggest that, in conjunction with the hypercapnia-hypoxia-mediated disturbance in renal function, stimulation of the renin-aldosterone level and of the AVP systems contributes, respectively, to edema formation and to hyponatremia in advanced COLD.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7046672

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  26 in total

Review 1.  Renal and hormonal abnormalities in chronic obstructive pulmonary disease (COPD).

Authors:  P Palange
Journal:  Thorax       Date:  1998-11       Impact factor: 9.139

Review 2.  [Extracardiac causes of right ventricular insufficiency].

Authors:  B Maisch; M Christ
Journal:  Internist (Berl)       Date:  2004-10       Impact factor: 0.743

3.  Vasopressin and oxytocin release during prolonged environmental hypoxia in the rat.

Authors:  H Kelestimur; R M Leach; J P Ward; M L Forsling
Journal:  Thorax       Date:  1997-01       Impact factor: 9.139

4.  Influence of pulmonary hypertension on survival in advanced lung disease.

Authors:  Don Hayes; Sylvester M Black; Joseph D Tobias; Heidi M Mansour; Bryan A Whitson
Journal:  Lung       Date:  2015-02-18       Impact factor: 2.584

5.  Renal functional reserve in patients with severe chronic obstructive pulmonary disease.

Authors:  R A Sharkey; E M Mulloy; I A Kilgallen; S J O'Neill
Journal:  Thorax       Date:  1997-05       Impact factor: 9.139

6.  Hypoxia and the heart.

Authors:  S W Davies; J A Wedzicha
Journal:  Br Heart J       Date:  1993-01

7.  Renal and pulmonary effects of angiotensin converting enzyme inhibition in chronic hypoxic lung disease.

Authors:  R M Oliver; A J Peacock; J S Fleming; D G Waller
Journal:  Thorax       Date:  1989-06       Impact factor: 9.139

8.  Effects of angiotensin converting enzyme inhibition on sodium excretion in patients with hypoxaemic chronic obstructive pulmonary disease.

Authors:  A G Stewart; J C Waterhouse; C G Billings; P Baylis; P Howard
Journal:  Thorax       Date:  1994-10       Impact factor: 9.139

Review 9.  The role of the renin-angiotensin and natriuretic peptide systems in the pulmonary vasculature.

Authors:  R I Cargill; B J Lipworth
Journal:  Br J Clin Pharmacol       Date:  1995-07       Impact factor: 4.335

10.  Atrial natriuretic peptide in stable and decompensated chronic obstructive pulmonary disease.

Authors:  K Skwarski; M Lee; L Turnbull; W MacNee
Journal:  Thorax       Date:  1993-07       Impact factor: 9.139

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.